Giant prolactinomas in men: efficacy of cabergoline treatment

Salvatore Maria Corsello; G Ubertini; M Altomare; Rm Lovicu; Mg Migneco; Carlo Antonio Rota; Cesare Colosimo

Giant prolactinomas in men: efficacy of cabergoline treatment

Salvatore Maria Corsello
, G Ubertini
, M Altomare
, Rm Lovicu
, Mg Migneco
, Carlo Antonio Rota
, Cesare Colosimo

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo

95 Citazioni (Scopus)

Abstract

The term 'giant prolactinoma' can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long-lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in micro- and macroprolactinomas. The purpose of this prospective study was to evaluate the efficacy and safety of CAB also for giant prolactinomas.

Lingua originale	Inglese
pagine (da-a)	662-670
Numero di pagine	9
Rivista	Clinical Endocrinology
Volume	58
Stato di pubblicazione	Pubblicato - 2003

Keywords

Adrenal Glands
Adult
Aged
Antineoplastic Agents
Erectile Dysfunction
Ergolines
Humans
Hypothyroidism
Libido
Magnetic Resonance Imaging
Male
Middle Aged
Pituitary Gland
Pituitary Neoplasms
Prolactin
Prolactinoma
Vision Disorders

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{c955f5fdaad04be5b57f8046b816680a,

title = "Giant prolactinomas in men: efficacy of cabergoline treatment",

abstract = "The term 'giant prolactinoma' can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long-lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in micro- and macroprolactinomas. The purpose of this prospective study was to evaluate the efficacy and safety of CAB also for giant prolactinomas.",

keywords = "Adrenal Glands, Adult, Aged, Antineoplastic Agents, Erectile Dysfunction, Ergolines, Humans, Hypothyroidism, Libido, Magnetic Resonance Imaging, Male, Middle Aged, Pituitary Gland, Pituitary Neoplasms, Prolactin, Prolactinoma, Vision Disorders, Adrenal Glands, Adult, Aged, Antineoplastic Agents, Erectile Dysfunction, Ergolines, Humans, Hypothyroidism, Libido, Magnetic Resonance Imaging, Male, Middle Aged, Pituitary Gland, Pituitary Neoplasms, Prolactin, Prolactinoma, Vision Disorders",

author = "Corsello, \{Salvatore Maria\} and G Ubertini and M Altomare and Rm Lovicu and Mg Migneco and Rota, \{Carlo Antonio\} and Cesare Colosimo",

year = "2003",

language = "English",

volume = "58",

pages = "662--670",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Giant prolactinomas in men: efficacy of cabergoline treatment

AU - Corsello, Salvatore Maria

AU - Ubertini, G

AU - Altomare, M

AU - Lovicu, Rm

AU - Migneco, Mg

AU - Rota, Carlo Antonio

AU - Colosimo, Cesare

PY - 2003

Y1 - 2003

N2 - The term 'giant prolactinoma' can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long-lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in micro- and macroprolactinomas. The purpose of this prospective study was to evaluate the efficacy and safety of CAB also for giant prolactinomas.

AB - The term 'giant prolactinoma' can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long-lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in micro- and macroprolactinomas. The purpose of this prospective study was to evaluate the efficacy and safety of CAB also for giant prolactinomas.

KW - Adrenal Glands

KW - Adult

KW - Aged

KW - Antineoplastic Agents

KW - Erectile Dysfunction

KW - Ergolines

KW - Humans

KW - Hypothyroidism

KW - Libido

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Pituitary Gland

KW - Pituitary Neoplasms

KW - Prolactin

KW - Prolactinoma

KW - Vision Disorders

KW - Adrenal Glands

KW - Adult

KW - Aged

KW - Antineoplastic Agents

KW - Erectile Dysfunction

KW - Ergolines

KW - Humans

KW - Hypothyroidism

KW - Libido

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Pituitary Gland

KW - Pituitary Neoplasms

KW - Prolactin

KW - Prolactinoma

KW - Vision Disorders

UR - http://hdl.handle.net/10807/13843

M3 - Article

SN - 0300-0664

VL - 58

SP - 662

EP - 670

JO - Clinical Endocrinology

JF - Clinical Endocrinology

ER -

Giant prolactinomas in men: efficacy of cabergoline treatment

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo